je.st
news
Craig Hallum Reiterates Buy Rating for Ligand Pharmaceuticals
2015-05-24 10:58:48| Biotech - Topix.net
's stock had its "buy" rating restated by investment analysts at Craig Hallum in a note issued to investors on Saturday. They currently have a $105.00 target price on the biotechnology company's stock, up from their previous target price of $90.00.
Tags: buy
rating
craig
pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||